You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 080029

✉ Email this page to a colleague

« Back to Dashboard

NDA 080029 describes SULFACETAMIDE SODIUM, which is a drug marketed by Fougera Pharms, Padagis Us, Sun Pharma Canada, Alcon Pharms Ltd, Bausch And Lomb, Chartwell Rx, Epic Pharma Llc, Pharmafair, Pharmobedient, and Genus, and is included in twelve NDAs. It is available from nine suppliers. Additional details are available on the SULFACETAMIDE SODIUM profile page.

The generic ingredient in SULFACETAMIDE SODIUM is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.

Summary for 080029

Tradename:	SULFACETAMIDE SODIUM
Applicant:	Padagis Us
Ingredient:	sulfacetamide sodium
Patents:	0

Pharmacology for NDA: 080029

Medical Subject Heading (MeSH) Categories for 080029

Anti-Infective Agents, Local
Anti-Infective Agents, Urinary

Suppliers and Packaging for NDA: 080029

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
SULFACETAMIDE SODIUM	sulfacetamide sodium	OINTMENT;OPHTHALMIC	080029	ANDA	Padagis US LLC	0574-4190	0574-4190-35	1 TUBE in 1 CARTON (0574-4190-35) / 3.5 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	OINTMENT;OPHTHALMIC			Strength	10%
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.